In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Epidauros Biotechnologie AG

Division of Allergan PLC
www.epidauros.com

Latest From Epidauros Biotechnologie AG

Biomarkers for Psychiatric Drugs: Outlier or Opportunity?

A handful of companies are pursuing predictive genetic tests for evaluating psychiatric drugs. The need is apparent, and an early success could trigger a rapid shift in thinking about the sustainability of building a business around biomarkers in a therapeutic area sometimes considered the least likely to benefit near term from their development. That said, firms in this area--and elsewhere--must be wary of leaning too heavily on pharma companies as supportive partners.
BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Pharmacogenetics-Pharmacogenomics
  • In Vitro Diagnostics
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • Allergan PLC
  • Senior Management
  • Manfred Zoltobrocki, PhD, CEO
    Hubert Wechner, CFO
    Hannes Arnold, PhD, Sr. Dir., Bus. Dev. & Mktg.
    Stephan Reschauer, PhD, Dir., Patents & Licensing
  • Contact Info
  • Epidauros Biotechnologie AG
    Phone: (49) 8158 9985 0
    Am Neuland 1
    Bernried, 82347
    Germany
Advertisement
Advertisement
UsernamePublicRestriction

Register